|
시장보고서
European Asthma Therapeutics Markets
|
Abstract
This Frost & Sullivan research service titled European Asthma Therapeutics
Markets provides key challenges, forecasts and recommendations for the asthma
therapeutics market. In this research, Frost & Sullivan' s expert analysts
thoroughly examine the following markets: short acting beta 2 agonists,
inhaled corticosteroids, combination therapies and leukotriene antagonists.
This analysis is available through our Pharmaceuticals and Biotechnology
Growth Partnership Service programme. With this programme, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
Table of Contents
1 MARKET OVERVIEW
- Introduction
- Disease Characteristics
- Epidemiology
- Market Definition and Segmentation
2 RESEARCH METHODOLOGY
- Research Objectives and Scope
3 INDUSTRY CHALLENGES
- Challenges For The Asthma Therapeutics Market
- Challenges Faced by the Pharmaceutical Companies
4 EUROPEAN ASTHMA THERAPEUTICS MARKET
- Overview and Definitions
- Introduction
- Market Engineering Measurements Analysis
- Market Drivers
- Market Restraints
- Current Therapeutic Options
- Future Therapeutic Approaches
- Current Treatment Guidelines
- Regulatory Affairs
- Competitive Analysis
- Profiles of Key Industry Participants
- Market Share Analysis
5 FORECASTS FOR THE EUROPEAN ASTHMA THERAPEUTICS MARKET
- Forecasts
- Patient Forecasts
- Market Revenue Forecasts
- Market Share Analysis By Drug Class
- Forecasts of Recent Entrants - Xolair
6 PRICING AND REIMBURSEMENT IN EUROPE
- Factors Affecting Pricing and Reimbursement in Europe
- Pricing and Reimbursement
7 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN ASTHMA THERAPEUTICS MARKET
- Market Engineering Recommendations
- Strategic Recommendations
8 DATABASE OF KEY INDUSTRY PARTICIPANTS
- Key Industry Participants
- Key Participants in the Asthma Therapeutics Market
9 DECISION SUPPORT DATABASES
|
